Empery Asset Management »

Nls Pharmaceutics shares owned by Empery Asset Management

Quarter-by-quarter ownership of Nls Pharmaceutics (NLSPW) shares owned by Empery Asset Management from 13F filings

Historical chart of Empery Asset Management investment in Nls Pharmaceutics

Tip: Access up to 7 years of quarterly data

All positions including Nls Pharmaceutics held by Empery Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nls Pharmaceutics by Empery Asset Management

Quarter filed Position value Share count Share price at filing
2022-09-30 $38k 150k 0.25
2022-06-30 $18k 150k 0.12
2022-03-31 $38k 150k 0.25

More positions owned by Empery Asset Management

89bio (ETNB)
Unity Biotechnology
Fat Brands *w Exp 07/16/202 (FATBW)
Greenwave Technology Solutio (GWAV)
Polished *w Exp 06/02/202 (POLWQ)
Sobr Safe (SOBR)
Mind Medicine Mindmed (MNMD)
Tc Biopharm Holdings *w Exp 02/08/202 (TCBPW)
Sellas Life Sciences Group I (SLS)
Medicenna Therapeutics Corp. (MDNAF)
Harbor Custom Development In *w Exp 10/04/202 (HCDZQ)
Hagerty *w Exp 12/02/202 (HGTY.WS)
Surrozen
Athenex
Surgepays *w Exp 10/22/202 (SURGW)

View all positions for Empery Asset Management

Top funds holding Nls Pharmaceutics

Hudson Bay Capital Management
UBS Group

View all funds holding Nls Pharmaceutics